查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1815541

2025年肉毒桿菌毒素全球市场报告

Botulinum Toxin Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年肉毒桿菌毒素市场规模将强劲成长，到2029年将达到113.6亿美元，复合年增长率为9.4%。预测期内的成长可归因于以下因素：美容医疗市场的扩张、製剂和给药方式的进步、治疗应用的多样化、全球人口老化、新兴市场需求的增长、患者认知度和接受度的提高以及全球市场的不断扩张。预测期内的主要趋势包括策略合作伙伴关係、个人化和精准医疗方法、新适应症的监管核准以及产品创新。

未来五年的预测成长率为9.4%，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会给美国神经病学中心带来重大挑战，因为这会增加从德国和瑞士进口的治疗性肉毒桿菌毒素的成本，限制运动障碍的治疗选择，并可能增加专科护理成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

预计未来几年，对美容手术的需求不断增长将推动肉毒桿菌毒素市场的扩张。美容手术包括各种美容治疗和介入措施，包括手术和非手术，旨在增强和改善个人外观。肉毒桿菌毒素用于放鬆目标肌肉并减少皱纹和细纹的出现。例如，2024 年 8 月，美国最大的医学图书馆美国国家医学图书馆 (NLM) 更新了其预测，预测 2023 年全球将成长 3.4%，整形外科医生将进行 3,490 万例美容和非手术手术。全球共进行了超过 1,910 万例非手术手术和 1,580 万例手术手术。在过去十年中，美容手术一直在逐渐增加，自 2021 年以来显着加速。仅在过去四年中，手术总量就增加了 40%。因此，由于整容手术需求的增加，肉毒桿菌市场正在经历成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肉毒桿菌：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球肉毒桿菌毒素市场：成长率分析
  • 全球肉毒桿菌毒素市场表现：规模与成长，2019-2024
  • 全球肉毒桿菌毒素市场预测：规模与成长，2024-2029年，2034年
  • 全球肉毒桿菌毒素：总目标市场（TAM）

第六章 市场细分

  • 全球肉毒桿菌毒素市场：按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • A型肉毒桿菌毒素
  • B型肉毒桿菌
  • 全球肉毒桿菌毒素市场：按应用、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 治疗药物
  • 美丽
  • 全球肉毒桿菌毒素市场（按最终用户、业绩和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科诊所
  • 皮肤科诊所
  • 其他最终用户
  • 全球肉毒桿菌毒素市场：细分：A 型肉毒桿菌毒素，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医疗用途
  • 美容应用
  • 全球肉毒桿菌毒素市场：细分：B 型肉毒桿菌毒素，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医疗用途

第七章 区域和国家分析

  • 全球肉毒桿菌毒素市场：区域分析、预测与预测，2019-2024 年、2024-2029 年、2034 年
  • 全球肉毒桿菌毒素市场：按国家、表现和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 肉毒桿菌毒素市场：竞争格局
  • 肉毒桿菌毒素市场：公司简介
    • Cigna Group Overview, Products and Services, Strategy and Financial Analysis
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Teijin Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Menarinin Group
  • Ipsen Group
  • Galderma SA
  • Daewoong Pharmaceuticals Co. Ltd.
  • Supernus Pharmaceuticals Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Hugel Inc.
  • Evolus Inc.
  • Medytox Inc.
  • Revance Therapeutics Inc.
  • Sinclair Pharma
  • US WorldMeds LLC
  • Hugh Source International Ltd.
  • MedivaPharma
  • Wigmore Medical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年肉毒桿菌市场：提供新机会的国家
  • 2029年肉毒桿菌毒素市场：细分市场带来新机会
  • 2029年肉毒桿菌毒素市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24760u

Botulinum toxin, commonly known as Botox, is a neurotoxic protein produced by the bacterium Clostridium botulinum, recognized as one of the most potent toxins known to humans. Its applications span both medical and cosmetic purposes, encompassing the treatment of muscle spasms, reduction of wrinkles, management of excessive sweating, and addressing specific eye and bladder disorders.

The primary types of botulinum toxins include botulinum toxin type A and botulinum toxin type B. Botulinum toxin type A is a neurotoxic protein produced by Clostridium botulinum, widely utilized in various medical and cosmetic procedures. These applications extend to both therapeutic and aesthetic uses, with diverse end-users such as hospitals, specialty clinics, dermatology clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The botulinum toxins market research report is one of a series of new reports from The Business Research Company that provides botulinum toxins market statistics, including botulinum toxins industry global market size, regional shares, competitors with a botulinum toxins market share, detailed botulinum toxins market segments, market trends, and opportunities, and any further data you may need to thrive in the botulinum toxins industry. This botulinum toxins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The botulinum toxin market size has grown strongly in recent years. It will grow from $7.32 billion in 2024 to $7.93 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to cosmetic applications, medical therapies, growth in aesthetic medicine, increased awareness and acceptance, research and development initiatives

The botulinum toxin market size is expected to see strong growth in the next few years. It will grow to $11.36 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expanding aesthetic medicine market, advancements in formulations and delivery, diversification of therapeutic uses, global aging population, rising demand in emerging markets, growing patient awareness and acceptance, global market expansion. Major trends in the forecast period include strategic collaborations, personalized and precision medicine approaches, regulatory approvals for new indications, product innovations.

The forecast of 9.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. neurology centers by increasing costs of therapeutic botulinum toxin imported from Germany and Switzerland, potentially limiting treatment options for movement disorders and raising specialty care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for aesthetic procedures is anticipated to drive the expansion of the botulinum toxin market in the coming years. Aesthetic procedures encompass various cosmetic treatments and interventions aimed at enhancing or improving an individual's appearance, which can be either surgical or non-surgical. Botulinum toxin is utilized in these procedures to relax targeted muscles and diminish the visibility of wrinkles and fine lines. For example, in August 2024, the US National Library of Medicine (NLM), the largest medical library in the United States, predicted a 3.4% global increase for 2023, with 34.9 million cosmetic surgeries and nonsurgical procedures performed by plastic surgeons, according to the latest projections. More than 19.1 million nonsurgical procedures and over 15.8 million surgical operations were conducted worldwide. Aesthetic procedures have seen a gradual rise over the past decade, with a notable acceleration since 2021. In the last four years alone, there has been a 40% increase in the total number of procedures. Therefore, the botulinum toxin market is experiencing growth due to the heightened demand for cosmetic operations.

The burgeoning global aging population is anticipated to propel the expansion of the botulinum toxin market in the coming years. The term 'aging population' refers to a demographic shift characterized by a growing proportion of elderly individuals within a society. Botulinum toxin stands out as a popular and minimally invasive solution widely embraced by the aging population to address wrinkles and fine lines, offering a non-surgical avenue to enhance facial aesthetics and attain a more youthful appearance. As reported by the World Health Organization (WHO) in October 2022, the worldwide population aged 60 years and older is on a rapid growth trajectory, projected to double by 2050, reaching an estimated 2.1 billion individuals. This demographic shift towards an increasingly elderly population significantly contributes to the rising demand for botulinum toxin procedures, thereby propelling the growth of the botulinum toxin market.

Product innovation stands out as a prominent trend driving advancements in the botulinum toxin market, with companies actively pursuing innovative solutions to maintain their market positions. An illustration of this trend is evident in the developments by Evolus Inc., a US-based medical aesthetics company, which obtained approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxin A) in Australia. Nuceiva, containing botulinum toxin type A, is specifically designed for aesthetic purposes, aimed at temporarily enhancing the appearance of moderate glabellar lines in adult patients. The product functions by interrupting nerve impulses within facial muscles, inducing relaxation, and effectively smoothing wrinkles resulting from facial expressions such as squinting and frowning.

Leading companies in the botulinum toxin market are concentrating on creating innovative solutions, such as indigenous botulinum toxin injections, to enhance treatment efficacy, minimize side effects, and meet the increasing demand for both aesthetic and therapeutic applications. Indigenous botulinum toxin injection refers to formulations of botulinum toxin that are developed and manufactured locally, rather than being imported from international suppliers. For example, in December 2022, Gufic Biosciences, an India-based pharmaceutical company, launched Zarbot, which is India's first indigenous botulinum toxin injection (Botulinum Toxin Type A), in collaboration with US-based Prime Bio. Zarbot utilizes a purified HALL strain and a specialized formulation that improves stability, allowing for extended storage. It is designed to treat various neurological conditions and meets European and British pharmacopeial standards, ensuring its biological potency is comparable to that of international brands.

In August 2024, Crown Laboratories, Inc., a US-based pharmaceutical firm, acquired Revance Therapeutics, Inc., for $924 million. This acquisition aims to establish a leading global entity in the aesthetics and skincare sector by merging innovative products like Daxxify, thereby enhancing product offerings, accelerating growth, and expanding the provider network for both companies. Revance Therapeutics Inc. is a biotechnology company that provides a botulinum toxin product called DaxibotulinumtoxinA (DAXI).

Major companies operating in the botulinum toxin market include Cigna Group, Pfizer Inc., AbbVie Inc., Teijin Pharma Ltd., Eisai Co. Ltd., Menarinin Group, Ipsen Group, Galderma S.A., Daewoong Pharmaceuticals Co. Ltd., Supernus Pharmaceuticals Inc., Merz Pharma GmbH & Co. KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Revance Therapeutics Inc., Sinclair Pharma, US WorldMeds LLC, Hugh Source International Ltd., MedivaPharma, Wigmore Medical, AesthetiCare, Lanzhou Institute of Biological Products Co Ltd., AestheticSource, Botox Cosmetic, Metabiologics Inc.

North America was the largest region in the botulinum toxin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the botulinum toxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the botulinum toxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The botulinum toxin market consists of sales of botulinum toxin C and botulinum toxin D and their related formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Botulinum Toxin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on botulinum toxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for botulinum toxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The botulinum toxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Botulinum Toxin Type A; Botulinum Toxin Type B
  • 2) By Application: Therapeutics; Aesthetics
  • 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
  • Subsegments:
  • 1) By Botulinum Toxin Type A: Medical Applications; Aesthetic Applications
  • 2) By Botulinum Toxin Type B: Medical Applications
  • Companies Mentioned: Cigna Group; Pfizer Inc.; AbbVie Inc.; Teijin Pharma Ltd.; Eisai Co. Ltd.; Menarinin Group; Ipsen Group; Galderma S.A.; Daewoong Pharmaceuticals Co. Ltd.; Supernus Pharmaceuticals Inc.; Merz Pharma GmbH & Co. KGaA; Hugel Inc.; Evolus Inc.; Medytox Inc.; Revance Therapeutics Inc.; Sinclair Pharma; US WorldMeds LLC; Hugh Source International Ltd.; MedivaPharma; Wigmore Medical; AesthetiCare; Lanzhou Institute of Biological Products Co Ltd.; AestheticSource; Botox Cosmetic; Metabiologics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Botulinum Toxin Market Characteristics

3. Botulinum Toxin Market Trends And Strategies

4. Botulinum Toxin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Botulinum Toxin Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Botulinum Toxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Botulinum Toxin Market Growth Rate Analysis
  • 5.4. Global Botulinum Toxin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Botulinum Toxin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Botulinum Toxin Total Addressable Market (TAM)

6. Botulinum Toxin Market Segmentation

  • 6.1. Global Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Botulinum Toxin Type A
  • Botulinum Toxin Type B
  • 6.2. Global Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutics
  • Aesthetics
  • 6.3. Global Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Dermatology Clinics
  • Other End Users
  • 6.4. Global Botulinum Toxin Market, Sub-Segmentation Of Botulinum Toxin Type A, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical Applications
  • Aesthetic Applications
  • 6.5. Global Botulinum Toxin Market, Sub-Segmentation Of Botulinum Toxin Type B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical Applications

7. Botulinum Toxin Market Regional And Country Analysis

  • 7.1. Global Botulinum Toxin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Botulinum Toxin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Botulinum Toxin Market

  • 8.1. Asia-Pacific Botulinum Toxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Botulinum Toxin Market

  • 9.1. China Botulinum Toxin Market Overview
  • 9.2. China Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Botulinum Toxin Market

  • 10.1. India Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Botulinum Toxin Market

  • 11.1. Japan Botulinum Toxin Market Overview
  • 11.2. Japan Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Botulinum Toxin Market

  • 12.1. Australia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Botulinum Toxin Market

  • 13.1. Indonesia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Botulinum Toxin Market

  • 14.1. South Korea Botulinum Toxin Market Overview
  • 14.2. South Korea Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Botulinum Toxin Market

  • 15.1. Western Europe Botulinum Toxin Market Overview
  • 15.2. Western Europe Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Botulinum Toxin Market

  • 16.1. UK Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Botulinum Toxin Market

  • 17.1. Germany Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Botulinum Toxin Market

  • 18.1. France Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Botulinum Toxin Market

  • 19.1. Italy Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Botulinum Toxin Market

  • 20.1. Spain Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Botulinum Toxin Market

  • 21.1. Eastern Europe Botulinum Toxin Market Overview
  • 21.2. Eastern Europe Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Botulinum Toxin Market

  • 22.1. Russia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Botulinum Toxin Market

  • 23.1. North America Botulinum Toxin Market Overview
  • 23.2. North America Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Botulinum Toxin Market

  • 24.1. USA Botulinum Toxin Market Overview
  • 24.2. USA Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Botulinum Toxin Market

  • 25.1. Canada Botulinum Toxin Market Overview
  • 25.2. Canada Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Botulinum Toxin Market

  • 26.1. South America Botulinum Toxin Market Overview
  • 26.2. South America Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Botulinum Toxin Market

  • 27.1. Brazil Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Botulinum Toxin Market

  • 28.1. Middle East Botulinum Toxin Market Overview
  • 28.2. Middle East Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Botulinum Toxin Market

  • 29.1. Africa Botulinum Toxin Market Overview
  • 29.2. Africa Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Botulinum Toxin Market Competitive Landscape And Company Profiles

  • 30.1. Botulinum Toxin Market Competitive Landscape
  • 30.2. Botulinum Toxin Market Company Profiles
    • 30.2.1. Cigna Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Teijin Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Botulinum Toxin Market Other Major And Innovative Companies

  • 31.1. Menarinin Group
  • 31.2. Ipsen Group
  • 31.3. Galderma S.A.
  • 31.4. Daewoong Pharmaceuticals Co. Ltd.
  • 31.5. Supernus Pharmaceuticals Inc.
  • 31.6. Merz Pharma GmbH & Co. KGaA
  • 31.7. Hugel Inc.
  • 31.8. Evolus Inc.
  • 31.9. Medytox Inc.
  • 31.10. Revance Therapeutics Inc.
  • 31.11. Sinclair Pharma
  • 31.12. US WorldMeds LLC
  • 31.13. Hugh Source International Ltd.
  • 31.14. MedivaPharma
  • 31.15. Wigmore Medical

32. Global Botulinum Toxin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Botulinum Toxin Market

34. Recent Developments In The Botulinum Toxin Market

35. Botulinum Toxin Market High Potential Countries, Segments and Strategies

  • 35.1 Botulinum Toxin Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Botulinum Toxin Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Botulinum Toxin Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer